abstract |
The present invention relates to 4-(1H-1,2,3-triazolyl-1-yl)pyrrolidine-2-carboxylic acid derivatives (I) having pharmacological activity towards the α<sub>2</sub>δ subunit of the voltage-gated calcium channel, to processes for the preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain. |